Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
2.590
0.00 (0.00%)
At close: Jan 22, 2026, 4:00 PM EST
2.590
0.00 (0.00%)
After-hours: Jan 22, 2026, 4:53 PM EST
Repare Therapeutics Employees
Repare Therapeutics had 129 employees as of December 31, 2024. The number of employees decreased by 50 or -27.93% compared to the previous year.
Employees
129
Change (1Y)
-50
Growth (1Y)
-27.93%
Revenue / Employee
$92,016
Profits / Employee
-$559,690
Market Cap
111.65M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 129 | -50 | -27.93% |
| Dec 31, 2023 | 179 | -1 | -0.56% |
| Dec 31, 2022 | 180 | 28 | 18.42% |
| Dec 31, 2021 | 152 | 50 | 49.02% |
| Dec 31, 2020 | 102 | 38 | 59.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 341 |
| Agenus | 316 |
| Karyopharm Therapeutics | 279 |
| Seer, Inc. | 134 |
| Inovio Pharmaceuticals | 134 |
| Fortress Biotech | 101 |
| Artiva Biotherapeutics | 89 |
| Acumen Pharmaceuticals | 61 |
RPTX News
- 6 days ago - Repare Shareholders Approve Acquisition by XenoTherapeutics, Inc. - Business Wire
- 4 weeks ago - Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration - Business Wire
- 2 months ago - Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for Proposed Transaction with XenoTherapeutics, Inc. - Business Wire
- 2 months ago - Halper Sadeh LLC Encourages RPTX and SEE Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewsWire
- 2 months ago - Repare Therapeutics Agrees To Acquisition As Board Cites Best Path For Stakeholder Value - Benzinga
- 2 months ago - Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc. - Business Wire
- 3 months ago - Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Business Wire
- 5 months ago - Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results - Business Wire